ID

16329

Descripción

Assessment of Endometrial Changes in Postmenopausal Women With Breast Cancer in Adjuvant Treatment With Anastrozole; ODM derived from: https://clinicaltrials.gov/show/NCT00623519

Link

https://clinicaltrials.gov/show/NCT00623519

Palabras clave

  1. 11/7/16 11/7/16 -
Subido en

11 de julio de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT00623519

Eligibility Breast Cancer NCT00623519

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
provision of informed consent
Descripción

informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
resectable breast cancer patients, with histological confirmation
Descripción

histological breast cancer

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0019638
UMLS CUI [1,2]
C0678222
UMLS CUI [1,3]
C1514888
patients eligible to receive hormonal adjuvant treatment with anastrozole
Descripción

hormone therapy with anastrozole

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0290883
UMLS CUI [1,2]
C0279025
they are allowed patients treated with adjuvant chemo or radiotherapy concurrently
Descripción

adjuvant chemo or radiotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0085533
UMLS CUI [2]
C1522449
patients previously treated with tamoxifen that had to withdraw treatment due to other reason than endometrial changes are allowed
Descripción

Tamoxifen treatment

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0039286
UMLS CUI [1,2]
C0949878
postmenopausal patients(aged 50 years or over/ without menses in the last months/ fsh level >40ui/l / women under 50 years with fsh levels>40ui/l).
Descripción

postmenopausal patients

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232970
women showing progesterone and/or estrogen receptors positive.
Descripción

progesterone and/or estrogen receptors positive.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1562029
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with evidence of metastatic disease
Descripción

metastatic disease

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1282506
UMLS CUI [1,2]
C0027627
patients unsuitable to receive the medication according the anastrozole label
Descripción

patients unsuitable to receive the medication according the anastrozole label

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0290883
UMLS CUI [1,2]
C3839996
patients not giving their informed consent
Descripción

informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430

Similar models

Eligibility Breast Cancer NCT00623519

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
informed consent
Item
provision of informed consent
boolean
C0021430 (UMLS CUI [1])
histological breast cancer
Item
resectable breast cancer patients, with histological confirmation
boolean
C0019638 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C1514888 (UMLS CUI [1,3])
hormone therapy with anastrozole
Item
patients eligible to receive hormonal adjuvant treatment with anastrozole
boolean
C0290883 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
adjuvant chemo or radiotherapy
Item
they are allowed patients treated with adjuvant chemo or radiotherapy concurrently
boolean
C0085533 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
Tamoxifen treatment
Item
patients previously treated with tamoxifen that had to withdraw treatment due to other reason than endometrial changes are allowed
boolean
C0039286 (UMLS CUI [1,1])
C0949878 (UMLS CUI [1,2])
postmenopausal patients
Item
postmenopausal patients(aged 50 years or over/ without menses in the last months/ fsh level >40ui/l / women under 50 years with fsh levels>40ui/l).
boolean
C0232970 (UMLS CUI [1])
progesterone and/or estrogen receptors positive.
Item
women showing progesterone and/or estrogen receptors positive.
boolean
C1562029 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
metastatic disease
Item
patients with evidence of metastatic disease
boolean
C1282506 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
patients unsuitable to receive the medication according the anastrozole label
Item
patients unsuitable to receive the medication according the anastrozole label
boolean
C0290883 (UMLS CUI [1,1])
C3839996 (UMLS CUI [1,2])
informed consent
Item
patients not giving their informed consent
boolean
C0021430 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial